Uroxatral
INDICATIONS
UROXATRAL (alfuzosin HCl extended-release tablets) is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia. UROXATRAL is not indicated for the treatment of hypertension.
DOSAGE AND ADMINISTRATION
The recommended dosage is one 10 mg UROXATRAL (alfuzosin HCl extended-release tablets) tablet daily to be taken immediately after the same meal each day. The tablets should not be chewed or crushed.
HOW SUPPLIED
UROXATRAL (alfuzosin HCl extended-release tablets) 10 mg is available as a round, three-layer tablet: one white layer between two yellow layers, debossed with X10. UROXATRAL is supplied as follows:
| Package | NDC Number |
| Bottles of 30 | 0024-4200-30 |
| Bottles of 100 | 0024-4200-10 |
| Hospital Unit Dose (blister packs containing 10 cards of 10 tablets each) | 0024-4200-20 |
Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
Protect from light and moisture.
Keep UROXATRAL out of reach of children.
sanofi-aventis U.S. LLC Bridgewater, NJ 08807. Revised April 2008. FDA rev date: 05/06/08
Generic Name: Alfuzosin HCl
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Health Extras
Why Men Don't Go to the Doc
Experts say "American men live sicker and die younger than American women." Here are some explanations as to why.See more WebMD Videos »
Uroxatral
Related Drugs
Health Resources
Updated & New
RxList does not provide medical advice, diagnosis or treatment.